Project DEAL in Germany Reaches Agreement with Springer Nature

Elsevier is now the only big scientific publisher that hasn’t struck a bargain with the German consortium of libraries and research institutions.

Written byAshley P. Taylor
| 2 min read
humboldt university berlin project deal academic publishing spring nature open-access

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: Humboldt University is one of the institutions represented by Project DEAL.
© ISTOCK.COM, MIODRAG MILUTINOVIC

A consortium of more than 700 research institutions and libraries in Germany has reached an open-access agreement with the publisher Springer Nature, it announced yesterday (August 22), as Science reports. According to the contract, researchers at members of the consortium, called Project DEAL, will be able to publish their articles open-access, meaning that the papers will be free for anyone to read, in exchange for a per-article fee paid by the author. Member institutions will also have full access to the journals’ online content, rather than having to pay subscription fees. The deal excludes Nature and other Nature brand journals, however.

The agreement and others like it function to shift the costs of scientific publishing away from journal readers and toward paper authors and their institutions. Because the cost is per article published, rather than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies